We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+13.86%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$450M
AUM Growth
+$44.2M
Cap. Flow
+$6.33M
Cap. Flow %
1.41%
Top 10 Hldgs %
82.16%
Holding
81
New
7
Increased
6
Reduced
2
Closed
4

Top Buys

1
BLUE
bluebird bio
BLUE
+$4.88M
2
CUE icon
Cue Biopharma
CUE
+$2.38M
3
PROF
Profound Medical
PROF
+$1.27M
4
MDXH icon
MDxHealth
MDXH
+$1.26M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.1M

Top Sells

1
DRRX
DURECT Corp
DRRX
+$6.57M
2
YEXT icon
Yext
YEXT
+$274K
3
EQRX
EQRx, Inc. Common Stock
EQRX
+$11.1K
4
EQRXW
EQRx, Inc. Warrant
EQRXW
+$8.02K
5
LLYVK icon
Liberty Live Group Series C
LLYVK
+$68

Sector Composition

1 Consumer Discretionary 20.98%
2 Healthcare 15.62%
3 Industrials 14.66%
4 Materials 10.64%
5 Financials 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WGS icon
76
GeneDx Holdings
WGS
$1.8B
$836 ﹤0.01%
304
– –
FAZEW
77
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
$323 ﹤0.01%
75,000
– –
DRRX
78
DELISTED
DURECT Corp
DRRX
– –
-2,637,965
Closed -$6.57M
YEXT icon
79
Yext
YEXT
$536M
– –
-43,263
Closed -$274K
EQRXW
80
DELISTED
EQRx, Inc. Warrant
EQRXW
– –
-200,000
Closed -$8.02K
EQRX
81
DELISTED
EQRx, Inc. Common Stock
EQRX
– –
-5,000
Closed -$11.1K
1 2 3
4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q4 2023 Portfolio in Review

As of Q4 2023, Bleichroeder LP held 81 positions worth $450M, up 11% from $406M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Bleichroeder LP's Q4 2023 filing shows 7 new, 6 increased, 2 reduced and 4 closed positions. Its largest new stake was Profound Medical: 133,333 shares worth $1.13M. The largest sale was DURECT Corp, an estimated $6.57M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Bleichroeder LP's largest Q4 2023 buy was Profound Medical: 133,333 shares worth $1.13M.
  • Bleichroeder LP added most to bluebird bio in Q4 2023, an estimated $4.88M increase.
  • Bleichroeder LP's biggest Q4 2023 reduction was Liberty Live Group Series C, cutting an estimated $68.
  • Bleichroeder LP fully exited DURECT Corp in Q4 2023, selling an estimated $6.57M.
  • Bleichroeder LP's ten largest holdings make up 82% of its $450M portfolio in Q4 2023.
  • Bleichroeder LP opened 7 new positions and closed 4 in Q4 2023.
  • Bleichroeder LP's portfolio value rose 11% quarter-over-quarter to $450M.

Based on Bleichroeder LP's 13F filing for Q4 2023, filed 12 Feb 2024.